Pfizer Inc. Message Board
-
ILNS is Potential Buyout Target for PFE
Intellect Neurosciences (OTCBB: ILNS), a very small, publicly traded micro-cap company which was, until just recently, in debt and struggling to survive, is now in line for a chunk of the profits from the $20+ billion Alzheimer's Disease space.
A newly published report reveals for the first time how Pfizer, Wyeth, Elan, and Johnson and Johnson have all focused on attacking the illness by licensing and devloping a protected platform technology from Intellect Neurosciences.
Bapineuzumab, in Phase 3 clinical trials, is being co-developed by Pfizer and Johnson & Johnson, and Ponezumab, in Phase 2 trials, is being developed by Pfizer. Both drug candidates are based on the use of antibodies that uniquely bind molecular signatures at the ends of beta amyloid formed when the Aβ toxin is generated. This is the fundamental principle of Intellect's ANTISENILIN(R) technology, which is intended to promote the clearance of amyloid protein away from sites of damage in the brain while minimizing the potential for adverse effects that may result from less specific binding.
the idea being they may want tottal controll...This topic is deleted.-
So what exactly stops Pfizer from buying this minute company? It sure isn't the price, Pfizer could sneeze and the residue is enough to buy up this company you are touting.
- 3 Replies to thisldu99
-
They are waiting for FDA approval first.
-
Hidden gem, up 9% today for good reasons.
-
this can do well with recent alzheimer's news
-
Wasn't this very same article by you posted on the JNJ message board. I am long with ILNS and believe in it 2
- 1 Reply to sportsindy
-
right on !
-
is that from the Adam Sandler movie real funny ! but a potential remedy for Alzheimer's is not some kind of joke many people can be helped for some its people close to them!
-
you don't mess with the Zohran,LMAO.
-
video discussion http://vimeo.com/channels/122997 Dr.Chain talks about how they are working on the alzheimer's problem
- 1 Reply to da.profit93
-
Would that be Doctor (ball and) Chain?
-
I've been in ILNS for awhile and I stumbled on to it from owning ELN. I believe "bap" will be approved now how much % we get I have no idea, but I owned TTNP at .02-.04 and watched it POP to 1.50 overnight before retracing. I sold later @ 2.25 avg and I'm back in now. If you study "bap" especially with the news of how ELN put together the trials, then you'd have the confidence that I do about ILNS.
I also did some DD on the bigger shareholders or debt holders, I can remember which who could have BK'd ILNS in February. I bought a bunch of shares under .03 because I knew that the DD I'd done showed me people who care about the cure more that just getting their money back. Which they converted debt and kept ILNS in the game. I sold most of those shares above .10 because of other 'plays' I wanted in and it's always good to take profits and ride "free shares" IMO
As far as management I don't know as well, but it doesn't seem like other stocks I've owned like ADLS who's management just seems to not care about shareholder value. I could be wrong but I don't get that from ILNS. We would easily move to .10 if people hold their shares, but that's a HUGE GAIN and I'd expect some traders to take profits at 25-50% once they're done I think the 100-500% gains will happen and I will ride some 'free shares' when we get closer to the bigger gains. Good luck with whatever your goal is here.
-